News on Factor_Vii_Deficiency from BioPortfolio.com http://www.BioPortfolio.com Consolidated Factor_Vii_Deficiency news from BioPortfolio.com Wed, 10 Feb 2010 14:33:06 GMT en Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension - pdf attachedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031864&HITNO=0&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031864&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031864&HITNO=0&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031864&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Hepatitis C and the Risk of Kidney Disease and Mortality in Veterans With HIV: "veterans coinfected with HCV have significantly higher rates of CKD and mortality"http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018360&HITNO=1&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018360&THISHREF=http://c.moreover.com/click/here.pl%3fz2525627522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018360&HITNO=1&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018360&THISHREF=http://c.moreover.com/click/here.pl%3fz2525627522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Severe Rheumatoid Arthritis Treatment available at Axium Healthcare Pharmacyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018109&HITNO=2&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018109&THISHREF=http://c.moreover.com/click/here.pl%3fz2525480778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018109&HITNO=2&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018109&THISHREF=http://c.moreover.com/click/here.pl%3fz2525480778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDBusinessNews.com: PROLOR Biotech Reports Merck Receives Final Marketing Authorization in Europe for Long-Acting CTP-Modified Fertility Treatment ELONVA(R) (FSH-CTP)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986709&HITNO=3&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986709&THISHREF=http://c.moreover.com/click/here.pl%3fz2509343315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986709&HITNO=3&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986709&THISHREF=http://c.moreover.com/click/here.pl%3fz2509343315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: IZA Joins Forces With UNICEF To Reduce Zinc Deficiency In Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987063&HITNO=4&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987063&THISHREF=http://c.moreover.com/click/here.pl%3fz2509572218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987063&HITNO=4&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987063&THISHREF=http://c.moreover.com/click/here.pl%3fz2509572218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Progestogen-only hormonal contraception linked to metabolic problems in HIV-positive womenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984017&HITNO=5&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984017&THISHREF=http://c.moreover.com/click/here.pl%3fz2507988309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984017&HITNO=5&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984017&THISHREF=http://c.moreover.com/click/here.pl%3fz2507988309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAidsmap: IZA Joins Forces with UNICEF to Reduce Zinc Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978970&HITNO=6&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978970&THISHREF=http://c.moreover.com/click/here.pl%3fz2505568438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978970&HITNO=6&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978970&THISHREF=http://c.moreover.com/click/here.pl%3fz2505568438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: IZA Joins Forces with UNICEF to Reduce Zinc Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978875&HITNO=7&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978875&THISHREF=http://c.moreover.com/click/here.pl%3fz2505514446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978875&HITNO=7&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978875&THISHREF=http://c.moreover.com/click/here.pl%3fz2505514446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Reportlinker Adds The Coagulation Testing Market: US, Europe, Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964573&HITNO=8&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964573&THISHREF=http://c.moreover.com/click/here.pl%3fz2498177138%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964573&HITNO=8&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964573&THISHREF=http://c.moreover.com/click/here.pl%3fz2498177138%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Reportlinker Adds The Coagulation Testing Market: US, Europe, Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962009&HITNO=9&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962009&THISHREF=http://c.moreover.com/click/here.pl%3fz2496989812%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962009&HITNO=9&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962009&THISHREF=http://c.moreover.com/click/here.pl%3fz2496989812%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIIIhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965326&HITNO=10&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965326&THISHREF=http://c.moreover.com/click/here.pl%3fz2498496308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965326&HITNO=10&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965326&THISHREF=http://c.moreover.com/click/here.pl%3fz2498496308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Pharma News: PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957935&HITNO=11&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957935&THISHREF=http://c.moreover.com/click/here.pl%3fz2495149234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957935&HITNO=11&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957935&THISHREF=http://c.moreover.com/click/here.pl%3fz2495149234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPoten & Partners: PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956639&HITNO=12&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956639&THISHREF=http://c.moreover.com/click/here.pl%3fz2494659567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956639&HITNO=12&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956639&THISHREF=http://c.moreover.com/click/here.pl%3fz2494659567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Reportlinker Adds The Coagulation Testing Market: US, Europe, Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958548&HITNO=13&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958548&THISHREF=http://c.moreover.com/click/here.pl%3fz2495434800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958548&HITNO=13&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958548&THISHREF=http://c.moreover.com/click/here.pl%3fz2495434800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKLFY: Reportlinker Adds The Coagulation Testing Market: US, Europe, Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958870&HITNO=14&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958870&THISHREF=http://c.moreover.com/click/here.pl%3fz2495542041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958870&HITNO=14&MSIZE=66&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Factor_Vii_Deficiency&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958870&THISHREF=http://c.moreover.com/click/here.pl%3fz2495542041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: